Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Bioequivalence study of SPARC147609
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | SPARC147609 |
|
| 2 | Active Comparator | Reference147609 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SPARC147609 | Drug | IV infusion |
| |
| Reference147609 |
| Measure | Description | Time Frame |
|---|---|---|
| 90% confidence interval of the relative mean Cmax, AUC0-t, AUC0-∞, of the test and reference product | 2 cycles |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment emergent adverse events | 2 cycles |
Not provided
Inclusion Criteria:
Subjects meeting all of the following criteria will be considered for enrollment in the study:
Exclusion Criteria:
History or presence of significant:
Donation of 350 mL or more of blood in the previous 90 days before day 1 of this study.
Participation in another clinical trial within the preceding 90 days of study start
Subjects who have:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| SPARC Site 1 | Hyderabaad | Andhra Pradesh | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29995186 | Derived | Bhowmik S, Bhowmick S, Maiti K, Chakra A, Shahi P, Jain D, Rajamannar T. Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil(R) or Caelyx(R) in advanced ovarian cancer. Cancer Chemother Pharmacol. 2018 Sep;82(3):521-532. doi: 10.1007/s00280-018-3643-3. Epub 2018 Jul 11. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| D002277 | Carcinoma |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
IV infusion |
|
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |